Analyst: Buy CRH Medical After An ‘Overdone’ Selloff

0 Comments 5 view(s)

CRH Medical Corp (NYSE: CRHM)’s 27 percent plunge on Friday in reaction to rate changes by the Medicare & Medicaid Services (CMS) is overdone and investors should consider buying shares on the weakness, Cannacord

Latest Ratings for CRHM

Date Firm Action From To
Dec 2016 Cantor Fitzgerald Initiates Coverage On Buy
Mar 2016 Canaccord Genuity Initiates Coverage on Buy

View More Analyst Ratings for CRHM

View the Latest Analyst Ratings

read more